Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124825972 | 12482597 | 2 | F | 20160521 | 20160630 | 20160620 | 20160707 | EXP | GB-MHRA-EYC 00140840 | GB-PFIZER INC-2016301257 | PFIZER | 59.00 | YR | F | Y | 68.00000 | KG | 20160707 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124825972 | 12482597 | 1 | PS | CLINDAMYCIN HCL | CLINDAMYCIN HYDROCHLORIDE | 1 | Oral | 150 MG, 4X/DAY | 3600 | MG | 50162 | 150 | MG | CAPSULE, HARD | QID | ||||
| 124825972 | 12482597 | 2 | SS | CIPROFLOXACIN HCL | CIPROFLOXACIN HYDROCHLORIDE | 1 | Oral | 250 MG, 2X/DAY | 3000 | MG | 0 | 250 | MG | BID | |||||
| 124825972 | 12482597 | 3 | SS | CIPROFLOXACIN HCL | CIPROFLOXACIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | Y | 0 | ||||||||||
| 124825972 | 12482597 | 4 | SS | CLINDAMYCIN HCL | CLINDAMYCIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | Y | 0 | ||||||||||
| 124825972 | 12482597 | 5 | C | BECONASE AQ | BECLOMETHASONE DIPROPIONATE MONOHYDRATE | 1 | 0 | ||||||||||||
| 124825972 | 12482597 | 6 | C | BISOPROLOL | BISOPROLOL | 1 | 1.25 MG, UNK | 0 | 1.25 | MG | |||||||||
| 124825972 | 12482597 | 7 | C | CETIRIZINE HYDROCHLORIDE. | CETIRIZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 124825972 | 12482597 | 8 | C | METRONIDAZOLE. | METRONIDAZOLE | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 124825972 | 12482597 | 9 | C | GENTAMICIN. | GENTAMICIN | 1 | 0 | ||||||||||||
| 124825972 | 12482597 | 10 | C | RABEPRAZOLE SODIUM. | RABEPRAZOLE SODIUM | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 124825972 | 12482597 | 11 | C | BUTTERCUP SYRUP (UK) | 2 | 0 | |||||||||||||
| 124825972 | 12482597 | 12 | C | GAVISCON DOUBLE ACTION | 2 | TAKEN OCCASIONALLY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124825972 | 12482597 | 1 | Antibiotic therapy |
| 124825972 | 12482597 | 2 | Antibiotic therapy |
| 124825972 | 12482597 | 3 | Cellulitis |
| 124825972 | 12482597 | 4 | Cellulitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124825972 | 12482597 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124825972 | 12482597 | Body temperature increased | |
| 124825972 | 12482597 | Chills | |
| 124825972 | 12482597 | Cough | |
| 124825972 | 12482597 | Dry mouth | |
| 124825972 | 12482597 | Erythema | |
| 124825972 | 12482597 | Feeling cold | |
| 124825972 | 12482597 | Pruritus | |
| 124825972 | 12482597 | Rash macular | |
| 124825972 | 12482597 | Skin warm | |
| 124825972 | 12482597 | Tongue coated |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124825972 | 12482597 | 1 | 20160515 | 20160522 | 0 | |
| 124825972 | 12482597 | 2 | 20160515 | 20160522 | 0 |